Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia: A Case Report

• Asıl Yazarlar: Christopher Bowman MD (Yazar), Vandana Abramson MD (Yazar), Melissa Wellons MD (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: SAGE Publishing, 2017-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Context . Many phosphoinositide-3-kinase (PI3K) inhibitors are under trial for cancer treatment. We present a patient taking taselisib who developed ketoacidosis within 1 week of starting canagliflozin. Case Description . A 69-year-old female patient with no previous history of diabetes mellitus was...